Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2010
07/08/2010WO2010077530A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof
07/08/2010WO2010077358A1 Methods for increasing endogenous plasmalogen levels
07/08/2010WO2010077317A2 Protease inhibitors
07/08/2010WO2010077310A2 Amide derivatives of ethacrynic acid
07/08/2010WO2010077295A1 Substituted tricyclic heterocycles and uses to treat tumors and proliferative disorders
07/08/2010WO2010077292A1 Pregnenolone sulfate for the treatment of neurologic disorders
07/08/2010WO2010077275A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
07/08/2010WO2010077201A1 A composition comprising nor-adrenaline and amphetamine for administering to a brain-dead, heart -beating potential organ donor
07/08/2010WO2010077200A1 A composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor.
07/08/2010WO2010077165A1 Phospholipid emulsion containing dihydroquercetin, and method of producing thereof
07/08/2010WO2010077156A1 Composition for prolonged release of heparin and use of the alginate-hydroxypropylcellulose gel for prolonged release of heparin
07/08/2010WO2010077152A1 Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
07/08/2010WO2010077101A2 Novel thiazolidinedione derivative and use thereof
07/08/2010WO2010077074A2 Preparation for the treatment of diabetes comprising arginine thiazolidine carboxylate or a derivative thereof
07/08/2010WO2010077061A2 Pharmaceutical formulations containing antiviral drugs
07/08/2010WO2010076935A1 Pharmaceutical composition comprising sirna specific for reduced expression-1 for treating the bcnu-resistance glioblastoma multiforme
07/08/2010WO2010076884A1 Novel fused ring compound and use thereof
07/08/2010WO2010076879A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
07/08/2010WO2010076813A1 Thienopyridines as pharmacologically active agents
07/08/2010WO2010076812A1 Topical herbal formulation for treatment of acne and skin disorders
07/08/2010WO2010076764A1 Irreversible egfr inhibitor compounds with antiproliferative activity
07/08/2010WO2010076731A2 Vitamin d promoting sunscreen
07/08/2010WO2010076596A1 Pharmaceutical formulations of olmesartan
07/08/2010WO2010076566A2 Indoles useful in the treatment of inflammation
07/08/2010WO2010076553A1 Sulfonamide compounds for the treatment of respiratory disorders
07/08/2010WO2010076525A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010WO2010076524A2 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
07/08/2010WO2010076418A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
07/08/2010WO2010076333A1 Novel use of fibrates
07/08/2010WO2010076258A1 Phenylalkyl-imidazole-bisphosphonate compounds
07/08/2010WO2010076248A1 Use of lna apob antisense oligomers for the treatment of acute coronary syndromes
07/08/2010WO2010076238A1 Substituted quinazoline compounds
07/08/2010WO2010076034A1 Toluidine sulfonamides and their use as-inhibitors
07/08/2010WO2010076033A1 Toluidine sulfonamides and their use
07/08/2010WO2010075986A1 Nitroprotein biomarkers for copd
07/08/2010WO2010075973A1 Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators
07/08/2010WO2010075962A1 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
07/08/2010WO2010075957A1 Substituted furancarboxamides, and use thereof
07/08/2010WO2010075937A1 Monohydrate of 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid
07/08/2010WO2010075930A1 Modification i of 4-({4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid
07/08/2010WO2010075891A1 Fibcd1 for the prevention and treatment of diseases
07/08/2010WO2010075869A1 Toluidine sulfonamides and their use
07/08/2010WO2010075863A1 Arginase inhibitors for the treatment of depression
07/08/2010WO2010075861A2 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
07/08/2010WO2010075801A1 Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
07/08/2010WO2010075765A1 Cefdinir acid double salt and its preparation
07/08/2010WO2010075665A1 A formulation of silibinin with high efficiency and prolonged action and the preparation method thereof
07/08/2010WO2010075663A1 A formulation of silymarin with high efficiency and prolonged action and the preparation method thereof
07/08/2010WO2010075636A1 Compounds and methods for treatment of influenza
07/08/2010WO2010075635A1 Combination therapies using nap
07/08/2010WO2010075631A1 Polymorphic form of 5-chloro-n-{[(5s)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxa-zolidin-5-yl]-methyl}thiophene-2-carboxamide
07/08/2010WO2010075611A1 Composition comprising proanthocyanidin, proteolytic enzyme and aloe vera/agave species substance
07/08/2010WO2010059038A3 Wet granulation of tenofovir, emtricitabine and efavirenz
07/08/2010WO2010057000A3 Neuraminidase inhibitors and uses thereof
07/08/2010WO2010056633A3 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
07/08/2010WO2010056527A3 B-biphenyl sulfonamide compounds as ion channel modulators
07/08/2010WO2010055304A3 Oxazole or imidazole derivatives for use in the treatment of autoimmune disesases, in particular multiple sclerosis
07/08/2010WO2010055164A3 Isoquinolone derivatives as inhibitors of plavivirus replication
07/08/2010WO2010055028A3 Crystalline forms of fingolimod hcl
07/08/2010WO2010054469A9 Appetite suppressing weight management composition comprising caralluma fimbriata, hoodia gordonii and cissus quadrangularis extracts
07/08/2010WO2010053902A3 Tryptase enzyme inhibiting aminothiophenols
07/08/2010WO2010053435A3 Compounds and methods for the treatment of inflammatory diseases of the cns
07/08/2010WO2010051541A3 Compositions containing delta-9-thc-amino acid esters and process of preparation
07/08/2010WO2010049485A3 Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate
07/08/2010WO2010049451A3 C-glycosidic analogues of alpha-galactosylceramids having immunostimulating and immunoregulating properties
07/08/2010WO2010049144A3 Ligands for modulation of orphan receptor-gamma (nr1f3 ) activity
07/08/2010WO2010048559A3 Phenylpyrazole inhibitors of store operated calcium release
07/08/2010WO2010048452A3 Polycyclic compounds and methods related thereto
07/08/2010WO2010048095A3 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor
07/08/2010WO2010048064A3 Drug delivery system and its use in the treatment of postherpetic neuralgia
07/08/2010WO2010045575A3 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders
07/08/2010WO2010043561A3 Regenerative therapy
07/08/2010WO2010042933A9 Inhibition and treatment of prostate cancer metastasis
07/08/2010WO2010042684A4 Pyrrolotriazine kinase inhibitors
07/08/2010WO2010041143A3 Oral vaccines for producing mucosal immunity
07/08/2010WO2010039668A3 Inhibitors of cyclin kinase inhibitor p21
07/08/2010WO2010038078A3 Nitrotyrosine assay
07/08/2010WO2010037054A3 Heteroaryl antagonists of prostaglandin d2 receptors
07/08/2010WO2010034011A3 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
07/08/2010WO2010033593A3 Rosin derived epoxides and curing agents
07/08/2010WO2010033014A3 Method for preparation of regenerative imidazolium reagents
07/08/2010WO2010028254A3 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
07/08/2010WO2010028051A3 Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors
07/08/2010WO2010027189A3 A new use for homoisoflavanone or a salt thereof
07/08/2010WO2010021750A3 Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
07/08/2010WO2010019698A3 Inhibition of calicivirus (norovirus)
07/08/2010WO2010016042A8 Treatment of retinal degeneration
07/08/2010WO2010015518A3 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
07/08/2010WO2010012806A3 Substituted indole sulfonamide compounds, their preparation and use as medicaments
07/08/2010WO2010010531A9 Composition for controlling increase in blood glucose
07/08/2010WO2010009139A3 Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors
07/08/2010WO2010007169A9 Pharmaceutical compositions comprising lignans and their derivatives for treating hyperplastic diseases
07/08/2010WO2009143039A3 Heterocyclic compounds as factor ixa inhibitors
07/08/2010WO2009141450A3 Liposomes for drug delivery and methods for preparation thereof
07/08/2010WO2009129361A3 Bryostatin analogues and methods of making and using thereof
07/08/2010WO2009079008A8 Benzopyrans and analogs as rho kinase inhibitors
07/08/2010WO2009071500A3 Organic compounds
07/08/2010WO2009053604A9 Influenza virus haemagglutinin-specific monoclonal antibodies
07/08/2010WO2009024631A9 A combination of inhibitors of tgfbeta-1 and matrix metalloproteins for use in the treatment of bone metastases, bone resorption and hypercalcaemia
07/08/2010US20100174222 Method and apparatus for acne treatment using low intensity light therapy
1 ... 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 ... 7860